Every 8-K that CME Group (CME) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow CME and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CME filings page.
CME Group Inc. (CME) announced a set of senior leadership changes in its finance and legal divisions. Jack Tobin, age 63, will be appointed Managing Director, Deputy Chief Financial Officer effective November 2, 2026, and is expected to become Chief Financial Officer in March 2027 when current President & CFO Lynne Fitzpatrick becomes CEO as previously disclosed. As CFO, Tobin will join the company’s management team.
Matthew Render, age 47, will succeed Tobin as Managing Director, Chief Accounting Officer effective November 2, 2026, after joining CME Group as Deputy Chief Accounting Officer in August 2026. The company states Render’s appointment is not pursuant to any arrangement with another person, there are no family relationships with directors or executives, and he has no material interests in related-party transactions requiring disclosure under Item 404(a) of Regulation S‑K. In the legal division, John Marchese will be promoted to General Counsel and join the management team later in September 2026, succeeding Jonathan Marcus, who is stepping down after serving as General Counsel since 2022.
CME Group Inc. reports that on August 11, 2026 it communicated pricing changes to its clients through Special Executive Report No. 9799, with the notice made available on the company’s website. The disclosure is presented under Regulation FD to ensure broad, non-selective dissemination of this information.
The report also identifies Exhibit 104 as the cover page formatted in Inline XBRL, supporting electronic data use and compliance with SEC technical requirements.
CME Group Inc. reported strong second-quarter 2026 results, with revenue of $1,706.2 million, operating income of $1,107.1 million, net income of $1,041.8 million and diluted EPS of $2.88. On an adjusted basis, operating income was $1,185.0 million, adjusted net income $1,081.7 million and adjusted diluted EPS $2.99.
Management highlighted that the first half of 2026 was the strongest in the company’s history, with record first-half revenue and adjusted profitability metrics. Q2 average daily volume was the third highest ever at 29.8 million contracts, and market data revenue rose 20% to a record $238.1 million. As of June 30, 2026, CME Group held $2.3 billion in cash and $3.4 billion of debt, while returning capital through approximately $468 million of dividends and $695 million of share repurchases in the quarter.
CME Group Inc. announced a planned leadership transition in which longtime Chairman and CEO Terrence A. Duffy will become Executive Chairman and President and CFO Lynne C. Fitzpatrick will become Chief Executive Officer. The change will take effect on the later of March 1, 2027 and the filing of CME’s 2026 Form 10-K.
Duffy will remain CEO until that transition date, then serve as Executive Chairman through December 31, 2027 under a transition agreement that generally preserves his current pay and benefits while modifying certain equity and bonus terms. Fitzpatrick will continue as President and CFO until the transition and will join the Board and its Executive Committee when she becomes CEO.
Under her new employment agreement, Fitzpatrick will receive a $1.2 million base salary, with an annual bonus target of 200% of salary and a long-term incentive target of 700% of salary, plus defined severance, equity-vesting and post-employment non-compete terms.
CME Group Inc. reported final voting results from its reconvened 2026 Annual Meeting of Shareholders. Proposals to eliminate the rights of Class B-1 and Class B-2 shareholders to elect their own directors did not pass, despite strong support from the combined Class A and B shares. A related amendment to the certificate of incorporation received majority approval but will not be filed because it was contingent on those governance changes and a Class B-3 proposal, which did not achieve quorum. All Class B-1 and Class B-2 directors standing for election were re-elected to serve until the 2027 annual meeting, while Class B-3 director Elizabeth A. Cook will continue as a holdover director until her successor is elected or she resigns.
CME Group Inc. held its 2026 annual meeting of shareholders on May 14, 2026, and reported the voting results. Shareholders representing 318,466,544 shares, or 87.78% of the 362,808,081 Class A and Class B shares outstanding as of March 16, 2026, were present in person or by proxy. Class B-1, B-2, B-3 and B-4 did not reach their required 33.3% quorum, so the proposals under Items 4 through 8 were adjourned to a virtual meeting on June 9, 2026. Equity director nominees were elected with strong majorities, and shareholders ratified Ernst & Young LLP as independent auditor for 2026. On an advisory basis, shareholders also approved compensation for the company’s named executive officers.
CME Group Inc., through its subsidiary Chicago Mercantile Exchange Inc., entered into Amendment No. 11 to its 364-day multi-currency credit facility with a syndicate of banks led by Bank of America and Citibank. The amended facility provides a $7 billion multi-currency revolving secured credit line, which is eligible to be increased to $10 billion. It is intended to provide temporary liquidity if a clearing firm or depositary fails to meet obligations, or if there is a disruption in the domestic payments system affecting settlements between CME and its clearing firms. Cash and U.S. Treasury guaranty fund contributions, along with performance bond assets under the CME rulebook, may be used as collateral, and CME must comply with a consolidated tangible net worth test.
CME Group Inc. reported record first-quarter 2026 results, with revenue of $1.88 billion, up 14% from a year earlier. Operating income rose to $1.31 billion, while net income reached $1.15 billion and diluted earnings per share were $3.18.
On a non-GAAP basis, adjusted operating income was $1.37 billion, adjusted net income was $1.22 billion and adjusted diluted EPS were $3.36, each at record levels. Trading activity was exceptionally strong, with average daily volume hitting an all-time high of 36.2 million contracts, up 22%, and non-U.S. volume rising 30%. The company also returned significant capital, paying approximately $2.7 billion in dividends and repurchasing $536 million of shares in the quarter.
CME Group Inc. filed a current report to furnish its earnings press release for the quarter and year ended December 31, 2025. The press release, dated February 4, 2026, is attached as Exhibit 99.1 and outlines the company’s financial results.
The release includes several non-GAAP financial measures, such as adjusted revenues, expenses, operating income, net income and earnings per share. Management states these are intended to supplement GAAP results and improve comparability with prior periods, and provides reconciliations to the most directly comparable GAAP figures in accordance with Regulation G.
CME Group Inc. filed an 8-K to note that on February 2, 2026 it communicated pricing changes to its clients through Special Executive Report 9676. The company states that a copy of this pricing notice has been posted to its website.
The disclosure is furnished under Item 7.01, meaning it is treated as information provided for Regulation FD purposes. CME Group clarifies that this information is not deemed “filed” under Section 18 of the Exchange Act and is not incorporated into other securities law filings unless specifically referenced.
CME Group Inc. furnished an 8-K announcing quarterly results. The company reported that a press release dated October 22, 2025, covering financial results for the quarter ended September 30, 2025, was furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).
The press release includes non-GAAP measures—revenues, expenses, operating income, net income, and earnings per share—with reconciliations to the most comparable GAAP metrics pursuant to Regulation G. The Item 2.02 information, including the exhibit, is furnished and not deemed filed under Section 18 of the Exchange Act.
CME Group Inc. reported that Jack Tobin, its Managing Director and Chief Accounting Officer, has decided to retire from the company. He informed the company of his decision on September 9, 2025 and will continue serving as Chief Accounting Officer until October 30, 2026, providing more than a year for transition.
Mr. Tobin has held the Chief Accounting Officer role since 2015 and has been with CME Group for over 23 years. The company states that his retirement is voluntary and is not due to any disagreements regarding its accounting, operations, policies or practices. CME Group plans to begin a search for his successor, and Mr. Tobin will work with that person to support a smooth handover of responsibilities.